CAPR Shares Outstanding History



Below is a table of the CAPR shares outstanding history going back to 11/21/2013:

Date CAPR Shares Outstanding
11/21/201387041
3/26/20141.17M
5/12/20141.17M
8/12/20141.17M
11/12/20141.17M
3/9/20151.62M
3/13/20151.62M
5/11/20151.62M
8/12/20151.63M
11/12/20151.63M
3/29/20161.80M
5/12/20161.80M
8/12/20161.80M
11/11/20162.14M
3/14/20172.14M
5/12/20172.26M
8/10/20172.35M
11/10/20172.57M
3/20/20182.77M
5/10/20182.91M
8/9/20183.07M
11/14/20183.11M
3/28/20193.37M
5/13/20193.47M
6/5/20193.47M
8/7/20193.74M
11/8/20194.25M
3/27/20208.91M
5/13/202014.26M
8/7/202019.72M
11/12/202020.45M
3/12/202122.80M
5/13/202122.88M
8/12/202123.02M
11/9/202124.15M
3/9/202224.30M
5/10/202224.32M
8/10/202224.35M
11/9/202225.24M
3/16/202325.26M
5/10/202325.27M
8/7/202325.78M
11/13/202330.79M
3/7/202431.40M

Also see: CAPR Market Cap History
CAPR YTD Return
CAPR Historical Shares Outstanding:
+77.14% CAGR
CAPR Historical Shares Outstanding: +77.14% CAGR

Mouse over chart for data details
11/21/2013 ...3/7/2024
Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Co.'s main program, CAP-1002, is focused on the development and commercialization of a cell therapy comprised of cardiosphere-derived cells, which are an endogenous population of stromal cells isolated from donated cells of healthy human hearts for the treatment of DMD. We show 44 historical shares outstanding datapoints in our coverage of CAPR's shares outstanding history.

Understanding the changing numbers of CAPR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CAPR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CAPR by allowing them to research CAPR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CAPR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Capricor Therapeutics (CAPR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CARA Shares Outstanding History
CARM Shares Outstanding History
CASI Shares Outstanding History
CASM Shares Outstanding History
CATB Shares Outstanding History
CATS Shares Outstanding History
CBAY Shares Outstanding History
CBIO Shares Outstanding History
CBLI Shares Outstanding History
CBM Shares Outstanding History
More Healthcare companies »

 

CAPR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.